Accuray (ARAY) Announces Its Addition to the Russell 2000 Index

Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will be included in the Russell 2000^® Index and the broad-market Russell 3000^® Index, which will be effective today.

"We are pleased to have earned inclusion in the Russell 2000^® Index, one of the most widely used benchmarks for small-cap stocks," said Suzanne Winter, president and CEO of Accuray. "This is an important milestone for Accuray as we continue to build momentum and expand global access to our innovative, market-leading radiation therapy technologies."

Membership in the Russell 3000^® Index means automatic inclusion in the large-cap Russell 1000^® Index or small-cap Russell 2000^® Index as well as in the appropriate growth and value style indexes. The Russell 3000^® Index encompasses the 3,000 largest U.S.-traded stocks by objective, market-capitalization rankings, and style attributes. Membership in these indexes is updated annually and remains in place for one year.

The Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. Approximately US$12.1 trillion in assets are benchmarked against Russell's U.S. indexes. Russell indexes are part of FTSE Russell, a leading global index provider.

For more information on the Russell 2000^® Index and the Russell U.S. Indexes Reconstitution, visit the "Russell Reconstitution" section on the FTSE Russell website.

You May Also Be Interested In

• Ainos launches second-generation AI Nose for industrial deployment
• Galmed's Aramchol shows added cell death in prostate cancer study
• Mynd.ai gets NYSE American compliance extension to December 2027